Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3314940
Max Phase: Preclinical
Molecular Formula: C15H26N5O12P3
Molecular Weight: 561.32
Molecule Type: Small molecule
Associated Items:
ID: ALA3314940
Max Phase: Preclinical
Molecular Formula: C15H26N5O12P3
Molecular Weight: 561.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)c1nc2c(N)ncnc2n1[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C15H26N5O12P3/c1-3-7(2)13-19-9-12(16)17-5-18-14(9)20(13)15-11(22)10(21)8(31-15)4-30-35(28,29)32-34(26,27)6-33(23,24)25/h5,7-8,10-11,15,21-22H,3-4,6H2,1-2H3,(H,26,27)(H,28,29)(H2,16,17,18)(H2,23,24,25)/t7?,8-,10-,11-,15-/m1/s1
Standard InChI Key: KTLPDNIZAKWJOR-XWHPDVPISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 561.32 | Molecular Weight (Monoisotopic): 561.0791 | AlogP: 0.00 | #Rotatable Bonds: 10 |
Polar Surface Area: 269.90 | Molecular Species: ACID | HBA: 13 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.38 | CX Basic pKa: 4.82 | CX LogP: -4.10 | CX LogD: -8.86 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.19 | Np Likeness Score: 0.72 |
1. Gillerman I, Lecka J, Simhaev L, Munkonda MN, Fausther M, Martín-Satué M, Senderowitz H, Sévigny J, Fischer B.. (2014) 2-Hexylthio-β,γ-CH2-ATP is an effective and selective NTPDase2 inhibitor., 57 (14): [PMID:24972256] [10.1021/jm401933c] |
Source(1):